Timpanogos Dialysis Center (DVA) is a medicare approved dialysis facility center in Provo, Utah and it has 0 dialysis stations. It is located in Utah county at 1055 N 500 W Ste 222, Provo, UT, 84604. You can reach out to the office of Timpanogos Dialysis Center (DVA) at (801) 356-8907. This dialysis clinic is managed and/or owned by Davita. Timpanogos Dialysis Center (DVA) has the following ownership type - Profit. It was first certified by medicare in March, 1999. The medicare id for this facility is 462524 and it accepts patients under medicare ESRD program.
| Name | Timpanogos Dialysis Center (DVA) |
|---|---|
| Location | 1055 N 500 W Ste 222, Provo, Utah |
| No. of Dialysis Stations | 0 |
| Medicare ID | 462524 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1055 N 500 W Ste 222, Provo, Utah, 84604 | |
| (801) 356-8907 | |
News Archive
Mary Ann Liebert, Inc. announces the release of a new peer-reviewed journal in an expanding area of systems neuroscience, Brain Connectivity. This timely new journal is positioned to become the premier source of cutting-edge basic and clinical neuroscience research aimed at better understanding of structural and functional connections in the brain and how these connections are altered by neurological disorders.
Scientists have determined the detailed structure of an essential piece of the telomerase enzyme, an important contributor to the vast majority of human cancers. Understanding the physical shape of the protein has led to a better understanding of how it acts to immortalize cells - and should help scientists design broadly effective cancer drugs.
Even caregivers whose children receive the first dose of influenza vaccine may be vaccine hesitant and have inaccurate beliefs regarding influenza vaccine and disease, according to a new American Academy of Pediatrics Pediatric Research in Office Settings study that was a collaboration between investigators at Children's Hospital of Philadelphia, Columbia University Irving Medical Center, and the AAP.
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that its Data Monitoring Committee has reviewed the initial safety data from all three patients in the first cohort and has recommended dose escalation to the second cohort.
Innovotech Inc. today announced its unaudited financial and operational results for the three and nine month periods ended September 30, 2009.
› Verified 6 days ago
| NPI Number | 1811139561 |
| Organization Name | Timpanogos Dialysis Center |
| Doing Business As | Total Renal Care Inc |
| Address | 1055 N 500 W Ste 222 Provo, Utah, 84604 |
| Phone Number | (801) 356-8907 |
News Archive
Mary Ann Liebert, Inc. announces the release of a new peer-reviewed journal in an expanding area of systems neuroscience, Brain Connectivity. This timely new journal is positioned to become the premier source of cutting-edge basic and clinical neuroscience research aimed at better understanding of structural and functional connections in the brain and how these connections are altered by neurological disorders.
Scientists have determined the detailed structure of an essential piece of the telomerase enzyme, an important contributor to the vast majority of human cancers. Understanding the physical shape of the protein has led to a better understanding of how it acts to immortalize cells - and should help scientists design broadly effective cancer drugs.
Even caregivers whose children receive the first dose of influenza vaccine may be vaccine hesitant and have inaccurate beliefs regarding influenza vaccine and disease, according to a new American Academy of Pediatrics Pediatric Research in Office Settings study that was a collaboration between investigators at Children's Hospital of Philadelphia, Columbia University Irving Medical Center, and the AAP.
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that its Data Monitoring Committee has reviewed the initial safety data from all three patients in the first cohort and has recommended dose escalation to the second cohort.
Innovotech Inc. today announced its unaudited financial and operational results for the three and nine month periods ended September 30, 2009.
› Verified 6 days ago
| NPI Number | 1831153840 |
| Organization Name | Timpanogos Dialysis Center |
| Doing Business As | No Roll Up Timpanogos Llc |
| Address | 1055 N 500 W Provo, Utah, 84604 |
| Phone Number | (801) 356-8907 |
News Archive
Mary Ann Liebert, Inc. announces the release of a new peer-reviewed journal in an expanding area of systems neuroscience, Brain Connectivity. This timely new journal is positioned to become the premier source of cutting-edge basic and clinical neuroscience research aimed at better understanding of structural and functional connections in the brain and how these connections are altered by neurological disorders.
Scientists have determined the detailed structure of an essential piece of the telomerase enzyme, an important contributor to the vast majority of human cancers. Understanding the physical shape of the protein has led to a better understanding of how it acts to immortalize cells - and should help scientists design broadly effective cancer drugs.
Even caregivers whose children receive the first dose of influenza vaccine may be vaccine hesitant and have inaccurate beliefs regarding influenza vaccine and disease, according to a new American Academy of Pediatrics Pediatric Research in Office Settings study that was a collaboration between investigators at Children's Hospital of Philadelphia, Columbia University Irving Medical Center, and the AAP.
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that its Data Monitoring Committee has reviewed the initial safety data from all three patients in the first cohort and has recommended dose escalation to the second cohort.
Innovotech Inc. today announced its unaudited financial and operational results for the three and nine month periods ended September 30, 2009.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 1 |
News Archive
Mary Ann Liebert, Inc. announces the release of a new peer-reviewed journal in an expanding area of systems neuroscience, Brain Connectivity. This timely new journal is positioned to become the premier source of cutting-edge basic and clinical neuroscience research aimed at better understanding of structural and functional connections in the brain and how these connections are altered by neurological disorders.
Scientists have determined the detailed structure of an essential piece of the telomerase enzyme, an important contributor to the vast majority of human cancers. Understanding the physical shape of the protein has led to a better understanding of how it acts to immortalize cells - and should help scientists design broadly effective cancer drugs.
Even caregivers whose children receive the first dose of influenza vaccine may be vaccine hesitant and have inaccurate beliefs regarding influenza vaccine and disease, according to a new American Academy of Pediatrics Pediatric Research in Office Settings study that was a collaboration between investigators at Children's Hospital of Philadelphia, Columbia University Irving Medical Center, and the AAP.
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that its Data Monitoring Committee has reviewed the initial safety data from all three patients in the first cohort and has recommended dose escalation to the second cohort.
Innovotech Inc. today announced its unaudited financial and operational results for the three and nine month periods ended September 30, 2009.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular peritoneal dialysis at the center | 22 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 141 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 97 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Mary Ann Liebert, Inc. announces the release of a new peer-reviewed journal in an expanding area of systems neuroscience, Brain Connectivity. This timely new journal is positioned to become the premier source of cutting-edge basic and clinical neuroscience research aimed at better understanding of structural and functional connections in the brain and how these connections are altered by neurological disorders.
Scientists have determined the detailed structure of an essential piece of the telomerase enzyme, an important contributor to the vast majority of human cancers. Understanding the physical shape of the protein has led to a better understanding of how it acts to immortalize cells - and should help scientists design broadly effective cancer drugs.
Even caregivers whose children receive the first dose of influenza vaccine may be vaccine hesitant and have inaccurate beliefs regarding influenza vaccine and disease, according to a new American Academy of Pediatrics Pediatric Research in Office Settings study that was a collaboration between investigators at Children's Hospital of Philadelphia, Columbia University Irving Medical Center, and the AAP.
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that its Data Monitoring Committee has reviewed the initial safety data from all three patients in the first cohort and has recommended dose escalation to the second cohort.
Innovotech Inc. today announced its unaudited financial and operational results for the three and nine month periods ended September 30, 2009.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Timpanogos Dialysis Center (DVA) with elevated calcium levels.
| Patients with hypercalcemia | 22 |
| Hypercalcemia patient months | 141 |
| Patients with Serumphosphor | 26 |
| Patients with Serumphosphor less than 3.5 mg/dL | 18 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 34 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 25 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 18 |
| Patients with Serumphosphor greater than 7 mg/dL | 6 |
News Archive
Mary Ann Liebert, Inc. announces the release of a new peer-reviewed journal in an expanding area of systems neuroscience, Brain Connectivity. This timely new journal is positioned to become the premier source of cutting-edge basic and clinical neuroscience research aimed at better understanding of structural and functional connections in the brain and how these connections are altered by neurological disorders.
Scientists have determined the detailed structure of an essential piece of the telomerase enzyme, an important contributor to the vast majority of human cancers. Understanding the physical shape of the protein has led to a better understanding of how it acts to immortalize cells - and should help scientists design broadly effective cancer drugs.
Even caregivers whose children receive the first dose of influenza vaccine may be vaccine hesitant and have inaccurate beliefs regarding influenza vaccine and disease, according to a new American Academy of Pediatrics Pediatric Research in Office Settings study that was a collaboration between investigators at Children's Hospital of Philadelphia, Columbia University Irving Medical Center, and the AAP.
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that its Data Monitoring Committee has reviewed the initial safety data from all three patients in the first cohort and has recommended dose escalation to the second cohort.
Innovotech Inc. today announced its unaudited financial and operational results for the three and nine month periods ended September 30, 2009.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 14 |
| Hospitalization Rate in facility | 42 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 492.2 |
| Hospitalization Rate: Lower Confidence Limit | 4.4 |
News Archive
Mary Ann Liebert, Inc. announces the release of a new peer-reviewed journal in an expanding area of systems neuroscience, Brain Connectivity. This timely new journal is positioned to become the premier source of cutting-edge basic and clinical neuroscience research aimed at better understanding of structural and functional connections in the brain and how these connections are altered by neurological disorders.
Scientists have determined the detailed structure of an essential piece of the telomerase enzyme, an important contributor to the vast majority of human cancers. Understanding the physical shape of the protein has led to a better understanding of how it acts to immortalize cells - and should help scientists design broadly effective cancer drugs.
Even caregivers whose children receive the first dose of influenza vaccine may be vaccine hesitant and have inaccurate beliefs regarding influenza vaccine and disease, according to a new American Academy of Pediatrics Pediatric Research in Office Settings study that was a collaboration between investigators at Children's Hospital of Philadelphia, Columbia University Irving Medical Center, and the AAP.
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that its Data Monitoring Committee has reviewed the initial safety data from all three patients in the first cohort and has recommended dose escalation to the second cohort.
Innovotech Inc. today announced its unaudited financial and operational results for the three and nine month periods ended September 30, 2009.
› Verified 6 days ago